Safeguarding the US Pharmaceutical Supply: Woodcock Discusses Challenges, Shift Overseas

Safeguarding the US Pharmaceutical Supply: Woodcock Discusses Challenges, Shift Overseas

Source: 
RAPS.org
News Tags: 
snippet: 

As drug and active pharmaceutical ingredient (API) manufacturing moves overseas to cut costs, quality and reliability concerns have been raised and the House Energy & Commerce Committee’s Subcommittee on Health met Wednesday to discuss the supply chain with one of the US Food and Drug Administration’s top officials and other experts.